Brakke Consulting has joined with VaxiAm LLC, located in Manhattan, Kansas, USA, to expand its consulting services into the Chinese animal health market.
VaxiAm is currently helping Chinese animal health companies to set up research and development laboratories in the US, to evaluate new technologies and products that can be licensed to China, and to identify business partners for animal health markets in China and the US.
Dr. Jishu Shi is the principal owner of VaxiAm LLC. A native of China, Shi received his doctor of veterinary medicine from the Beijing/China Agricultural University in 1985, a master’s in science from the Chinese Academy of Agricultural Science in 1988, a doctorate in immunophysiology from Kansas State University in Manhattan in 1995 and completed postdoctoral research in immunology at the University of California, Los Angeles in 1998. Among his credentials, Dr. Shi is an associate professor for the college of veterinary medicine at Kansas State University and also the director of the US-China Center for Animal Health, which is a training center for the improvement of Chinese animal health education and research.
“Many of our clients are interested in marketing their products or services to a rapidly growing Chinese animal health market,” said Ronald Brakke, president and CEO of Brakke Consulting. “As part of VaxiAm, Dr. Shi brings his expertise and connections in the Chinese animal health industry. We also believe that Brakke’s extensive experience and knowledge will benefit Chinese firms desiring to enter the U.S. and European animal health markets.”
Pet owners want a lot from their pet food brands. They want primary proteins that suit what they believe is best for their animal. They want grains or they don't. They want something customized, but it has to be easy to understand.
Constraints and crises, like those experienced in 2020, help drive innovation and sustainability offers context.